| Tag | Content |
|---|
EnhancerAtlas ID | HS060-19033 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr2:38936810-38937690 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MAX | MA0058.3 | chr2:38937157-38937167 | ACCACGTGCT | + | 6.02 | | Pou2f3 | MA0627.1 | chr2:38937042-38937058 | CCTTATGCAAATTTGA | + | 6.35 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_14971 | chr2:38935747-38937117 | CD4_Memory_Primary_7pool | | SE_18097 | chr2:38935464-38938014 | CD4p_CD25-_CD45ROp_Memory | | SE_18777 | chr2:38935555-38937805 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19393 | chr2:38935628-38937704 | CD4p_CD25-_Il17p_PMAstim_Th17 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I038709 | chr2 | 38936245 | 38937415 |
|
Enhancer Sequence | GATCTGTGAA AAATGTATAG AAATGTTACC TTACCAAAAA ATTCCCAAGG TGCTTTACTT 60
GCCAACCACT GGAAGGAAGT AAAAATTCCC ACCCAGGGTG TTACTTTTAA TTATCATCCT 120
CTTTATGTTG TTTCCTAAAA TAACAACAGG CATTCTAGAG ATGATTTACG AAGATGGCTT 180
AATGAGGTGT CAGATGAGTA CCTGTGCCCA TGAGCCCCTT TACCGCAGGC CTCCTTATGC 240
AAATTTGACT GACTCTTCTG AGCCCGACTA GATAAAGAAA CAGACATAAT TGGAGCAGCT 300
GGGCTGGAAG CACAGCTGGG CTATCCTCAT GGAGACCAGA CTCTAGCACC ACGTGCTCTT 360
CCTGCTGCCC CAGTGTCCCT CCCAACTTTT GCTTTTCAGA GCAGCAGCCC ACCTGAACCT 420
GGGGCTTCCT CAGATGATCT CCACATCAGT GCTTGTCAGC ATTCATGTGC ACACAGATCA 480
CCTGTGCAAC TTGTGAAAAT GCAGATTCAG ACTCAGTGGC TGGAGTGGAG CCTCTGGATC 540
TATGTGTCTA ACAAGCCCCT GGGTGATGCA TGTGGTCATC AGATGGTCCT AGGTCCACAC 600
TTGGAGGAGC TATTTAGAGC CTATAAAATA GTTACTCCCC TATCCAGTGT TTGAGTCCCA 660
GACTTCTGCA TTCTGCCAGC ACTCAGATGC TTCTGGGACA GGATGCTTAC TGTGCATCTT 720
GGGTCAACAT GTCAAAAAGG CCTTCCTGTA TTGAGGTGAG ATCTGTCTAC CTAGGGCTCA 780
CCCTCACCTG GCCTACTTCT GGGCCTTGGA TCCTATGTAG CAGGCTTAAG GCATTAGAAA 840
GTGGCTGGCA TGTCCCCCAA GTATTTTATT CAGGCAAAAC 880
|
